Submitted by Anonymous (not verified) on 24 October 2024 - 14:50
Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 February 2026 to 12 February 2026
Source: